Lisa Fraleigh
Psychiatry · Logan, UTNPI 1558478115
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,367 of the $7,769 with a category attached, or 82.0%. 23 manufacturers reported payments, led by Neuronetics, Inc. at 26.1% of the total. Reporting peaked in 2024 at $3,188 and has fallen 69.6% since, to $970 in 2025. Among psychiatry clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Supernus Pharmaceuticals, Inc.$841
- Teva Pharmaceuticals USA, Inc.$806
- AbbVie$481
- Neurocrine Biosciences, Inc.$335
- plus $2K from 17 others
What the payments were for
- Travel & lodging$1,08514%
- Food & beverage$6,36782%
- Education$3174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 7 | $2,024 |
| Otsuka America Pharmaceutical, Inc. | 86 | $1,229 |
| Supernus Pharmaceuticals, Inc. | 35 | $841 |
| Teva Pharmaceuticals USA, Inc. | 35 | $806 |
| AbbVie(2 entities) | 36 | $481 |
| Neurocrine Biosciences, Inc. | 18 | $335 |
| Johnson & Johnson | 16 | $326 |
| Sunovion Pharmaceuticals Inc. | 25 | $278 |
| Ironshore Pharmaceuticals Inc. | 14 | $259 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $214 |
| Corium, LLC | 11 | $200 |
| Lundbeck LLC | 12 | $200 |
| Idorsia Pharmaceuticals US Inc | 7 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Alkermes, Inc. | 3 | $60 |
| Tris Pharma Inc | 2 | $45 |
| Shire North American Group Inc | 3 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Noven Therapeutics, LLC | 1 | $25 |
| Cranial Technologies, Inc | 1 | $18 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,832
- QELBREE$403
How this compares
$7,769 in reported general payments places this provider in the 95th percentile of 231 psychiatry providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 13 | $2,279 |
| Ziprasidone Hcl | 28 | $1,011 |
| Trazodone Hcl | 55 | $965 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 18 | $417 |
| Bupropion XlBupropion Hcl | 14 | $416 |
| Quetiapine Fumarate | 22 | $336 |
| Lorazepam | 12 | $312 |
| Sertraline Hcl | 23 | $197 |
| Duloxetine Hcl | 29 | $155 |
| Lithium Carbonate | 13 | $149 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $120 |
| Hydroxyzine Pamoate | 11 | $111 |
| Clonazepam | 40 | $100 |
| Gabapentin | 27 | $92 |
| Lamotrigine | 15 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Logan
- Michael MeasomSlc$2.2M
- Noel GardnerSalt Lake City$512K
- Reid RobisonOrem$133K
- Thomas RaynerProvo$60K
- Trent HolmbergDraper$32K
- Nathan CurrierRiverton$21K
- Oliver McPhersonBountiful$20K
- Frederick ReimherrSalt Lake City$18K
- Clark JohnsonSalt Lake City$7K
- Benjamin van LeeuwenLayton$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.